Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

This discovery suggests that NR may impact metabolic pathways involved in neurodegenerative diseases like Alzheimer’s. The research, funded by the National Institutes of Health (NIH), was ...

Many, including Alzheimer's disease, are treatable. Others, such as depression, thyroid problems, severe nutritional deficiency, or medication interaction, may be reversible. Patients who are ...

Fenamate NSAIDs inhibit the NLRP3 inflammasome and 2 protect against Alzheimer’s disease in rodent models, published in the journal Nature Communications. DOI: 10.1038/NCOMMS12504 Please note, this ...

These treatments are only effective for people with Alzheimer’s disease, dementia with Lewy bodies ... Standard tablets and capsules release the medication into the body as soon as they are swallowed.

Hints that the removal of amyloid plaques — which are a defining feature of Alzheimer's disease — may not be essential for improving cognition, could have implications for future treatments.

Walsh et al. examine how dementia impacts daily life and well-being over three years by tracking changes in behaviour, memory, and daily activities, for people with dementia and their carers.

Alzheimer's leans to memory loss then progressive failure of mental and physical functions Early results in a new treatment for one of the most common forms of dementia have been "absolutely ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...